Tocainide for refractory ventricular arrhythmias of myocardial infarction

Charles I. Haffajee, Joseph S Alpert, James E. Dalen

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Oral tocainide was used as a long-term antiarrhythmic in patients with symptomatic high-grade ventricular ectopic activity refractory to conventional antiarrhythmic agents. Eleven of the 22 patients had a previous myocardial infarction (three patients had a ventricular aneurysm). Unacceptable side effects precluded long-term use of tocainide in two patients. Long-term tocainide was effective in six of the remaining patients for periods of 9 days to 42.5 months (mean 15.2 months). Eight of these nine patients responded to intravenous lidocaine prior to tocainide therapy.

Original languageEnglish (US)
Pages (from-to)1013-1016
Number of pages4
JournalAmerican Heart Journal
Volume100
Issue number6 PART 2
DOIs
StatePublished - 1980
Externally publishedYes

Fingerprint

Tocainide
Cardiac Arrhythmias
Myocardial Infarction
Lidocaine
Aneurysm

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Tocainide for refractory ventricular arrhythmias of myocardial infarction. / Haffajee, Charles I.; Alpert, Joseph S; Dalen, James E.

In: American Heart Journal, Vol. 100, No. 6 PART 2, 1980, p. 1013-1016.

Research output: Contribution to journalArticle

Haffajee, Charles I. ; Alpert, Joseph S ; Dalen, James E. / Tocainide for refractory ventricular arrhythmias of myocardial infarction. In: American Heart Journal. 1980 ; Vol. 100, No. 6 PART 2. pp. 1013-1016.
@article{dc62bb2e2e7c48e98e5680b31d441eea,
title = "Tocainide for refractory ventricular arrhythmias of myocardial infarction",
abstract = "Oral tocainide was used as a long-term antiarrhythmic in patients with symptomatic high-grade ventricular ectopic activity refractory to conventional antiarrhythmic agents. Eleven of the 22 patients had a previous myocardial infarction (three patients had a ventricular aneurysm). Unacceptable side effects precluded long-term use of tocainide in two patients. Long-term tocainide was effective in six of the remaining patients for periods of 9 days to 42.5 months (mean 15.2 months). Eight of these nine patients responded to intravenous lidocaine prior to tocainide therapy.",
author = "Haffajee, {Charles I.} and Alpert, {Joseph S} and Dalen, {James E.}",
year = "1980",
doi = "10.1016/0002-8703(80)90206-9",
language = "English (US)",
volume = "100",
pages = "1013--1016",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "6 PART 2",

}

TY - JOUR

T1 - Tocainide for refractory ventricular arrhythmias of myocardial infarction

AU - Haffajee, Charles I.

AU - Alpert, Joseph S

AU - Dalen, James E.

PY - 1980

Y1 - 1980

N2 - Oral tocainide was used as a long-term antiarrhythmic in patients with symptomatic high-grade ventricular ectopic activity refractory to conventional antiarrhythmic agents. Eleven of the 22 patients had a previous myocardial infarction (three patients had a ventricular aneurysm). Unacceptable side effects precluded long-term use of tocainide in two patients. Long-term tocainide was effective in six of the remaining patients for periods of 9 days to 42.5 months (mean 15.2 months). Eight of these nine patients responded to intravenous lidocaine prior to tocainide therapy.

AB - Oral tocainide was used as a long-term antiarrhythmic in patients with symptomatic high-grade ventricular ectopic activity refractory to conventional antiarrhythmic agents. Eleven of the 22 patients had a previous myocardial infarction (three patients had a ventricular aneurysm). Unacceptable side effects precluded long-term use of tocainide in two patients. Long-term tocainide was effective in six of the remaining patients for periods of 9 days to 42.5 months (mean 15.2 months). Eight of these nine patients responded to intravenous lidocaine prior to tocainide therapy.

UR - http://www.scopus.com/inward/record.url?scp=0019195647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019195647&partnerID=8YFLogxK

U2 - 10.1016/0002-8703(80)90206-9

DO - 10.1016/0002-8703(80)90206-9

M3 - Article

C2 - 6778188

AN - SCOPUS:0019195647

VL - 100

SP - 1013

EP - 1016

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 6 PART 2

ER -